High levels of expression of the transcription factor Brachyury induce resistance of human carcinoma cells to immune-mediated attack
Main Authors: | Hamilton, Duane H, Huang, Bruce, Fernando, Romaine I, Tsang, Kwong-Yok, Palena, Claudia |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991195/ |
Similar Items
-
Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
by: Hamilton, Duane H., et al.
Published: (2014) -
Brachyury, a driver of tumor invasiveness and resistance to multiple therapies, is a novel immunotherapy target
by: Palena, Claudia, et al.
Published: (2013) -
MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition
by: David, Justin M., et al.
Published: (2016) -
The role of oncogenic MUC1-C in brachyury-induced immunotherapy resistance
by: David, Justin, et al.
Published: (2014) -
Upregulation of oncogenic MUC1 by the EMT transcription factor brachyury mediates immunotherapy-resistance in tumor cells
by: David, Justin M, et al.
Published: (2015)